Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.30
-0.61 (-7.71%)
At close: Apr 28, 2026, 4:00 PM EDT
7.90
+0.60 (8.22%)
After-hours: Apr 28, 2026, 7:25 PM EDT
Alpha Tau Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 10.22 | 9.02 | 9.26 | 11.25 | 2.34 | |
| Research & Development | 32.07 | 27.02 | 26.42 | 20.89 | 11.45 | |
| Operating Expenses | 42.29 | 36.04 | 35.68 | 32.14 | 13.79 | |
| Operating Income | -42.29 | -36.04 | -35.68 | -32.14 | -13.79 | |
| Interest Expense | -0.35 | -0.3 | -0.08 | - | - | |
| Interest & Investment Income | 3.84 | 4.28 | 4.83 | 1.79 | 0.21 | |
| Currency Exchange Gain (Loss) | -1.62 | 0.11 | -0.21 | 0.41 | -0.41 | |
| Other Non Operating Income (Expenses) | -2.09 | 0.22 | 1.99 | -3.81 | -13.27 | |
| Pretax Income | -42.51 | -31.74 | -29.14 | -33.74 | -27.26 | |
| Income Tax Expense | 0.12 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Earnings From Continuing Operations | -42.63 | -31.75 | -29.16 | -33.76 | -27.27 | |
| Net Income | -42.63 | -31.75 | -29.16 | -33.76 | -27.27 | |
| Net Income to Common | -42.63 | -31.75 | -29.16 | -33.76 | -27.27 | |
| Shares Outstanding (Basic) | 81 | 70 | 69 | 64 | 41 | |
| Shares Outstanding (Diluted) | 81 | 70 | 69 | 64 | 41 | |
| Shares Change (YoY) | 15.24% | 0.79% | 9.20% | 56.74% | 0.65% | |
| EPS (Basic) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | |
| EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.67 | |
| Free Cash Flow | -32.76 | -22.02 | -24.36 | -24.78 | -14.74 | |
| Free Cash Flow Per Share | -0.41 | -0.32 | -0.35 | -0.39 | -0.36 | |
| EBITDA | -41.06 | -34.94 | -34.61 | -31.16 | -13.01 | |
| D&A For EBITDA | 1.23 | 1.1 | 1.07 | 0.98 | 0.78 | |
| EBIT | -42.29 | -36.04 | -35.68 | -32.14 | -13.79 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.